Genematrix amends semiannual report after omitting treasury stock attachment
Genematrix filed a corrected semi-annual report for the six months ended June 30, 2026, adding the omitted treasury share disclosure. Treasury shares were unchanged at 429,477 common shares, and the treasury share ratio was revised to 2.11% from 2.15%. The company reiterated no short-term treasury share acquisition, di